Market Updates

Omacor Wins

Omacor Wins
Approval In Norway
Omacor, produced by Pronova Biocare, Lysaker, Norway, has been approved in Norway for the treatment of post-infarct patients. The formulation is more than 90% omega 3 (84% EPA and DHA) and one capsule per day dosing enhances patient compliance. In clinical trials, side effects were few, transient and mild.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters